Trial intelligence / Profile preview

Amiodarone for Ebola virus disease in Sierra Leone

PACTR201501001014425Unknown

Sponsor
EMERGENCY
Start
Feb 2015
Modality
Small Molecules
Countries
1
01

Overview

Open-label trial of amiodarone in Ebola virus disease (EVD) (2 arms), sponsored by EMERGENCY. Primary endpoint: Overall survival at day 10. Status: unknown.

02

Drugs

amiodarone
03

Conditions

Ebola virus disease (EVD)

Beyond the preview

Go deeper on PACTR201501001014425.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on PACTR201501001014425.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call